Functional changes can be made while processing pharmaceuticals, according to an article on the Healthcare Packaging website.
Upgrades during a shutdown pose less risk, but there are instances when a facility must expand capacity while maintaining some processing.
It is critical to maintain control of production while keeping the involved workers and the products safe.
A company will need to revalidate any system modified during a facility change, and the extent of the change may also require a re-inspection by the FDA.
Mature Dry Surface Biofilm Presents a Problem for Candida Auris
Sutter Health's Arden Care Center Officially Opens
Insight Hospital and Medical Center Falls to Data Breach
The High Cost of Healthcare Violence
EVS Teams Can Improve Patient Experience in Emergency Departments